PKK Library

Your cart is empty.

Welcome to P K Kelkar Library, Online Public Access Catalogue (OPAC)

Normal view MARC view ISBD view

Sutureless Anastomoses : Secrets for Success /

By: Tozzi, Piergiorgio [author.].
Contributor(s): SpringerLink (Online service).
Material type: materialTypeLabelBookPublisher: Darmstadt : Steinkopff, 2007.Description: XII, 140 p. online resource.Content type: text Media type: computer Carrier type: online resourceISBN: 9783798517158.Subject(s): Medicine | Cardiac surgery | Vascular surgery | Medicine & Public Health | Cardiac Surgery | Vascular SurgeryDDC classification: 617.412 Online resources: Click here to access online
Contents:
Historical overview of vascular anastomoses -- The physiology of blood flow and artery wall -- Mathematic modelling of vascular anastomoses -- Determinants of anastomosis long term patency -- Key issues in sutureless vascular anastomoses -- Coronary surgery: devices for proximal anastomosis -- Coronary surgery: devices for distal anastomoses -- Sutureless anastomotic devices for vascular surgery -- Human body and metal alloys: the never ending fight -- Criteria for vascular anastomosis devices assessment.
In: Springer eBooksSummary: When doctors first look at sutureless anastomosis devices created by new technologies, the most frequent comment is how amazingly easy it is to create a vascular anastomosis and, as a direct consequence, they believe anybody could play the role of the cardiovascular surgeon. Pessimistic c- diovascular surgeons, on their side, think that creating a machine capable of perfectly reproducing their core activity, which consists in making an- tomosis, will kill their profession. Actually, no medical specialty’s demise has been more often predicted and, at the same time, more greatly ex- gerated than that of cardiovascular surgery. According to its detractors, - ginning in the late 1980s with the angioplasty boom, continuing in the mid-1990s with the introduction of bare metal stents, and then more - cently with the introduction of drug-eluting stents, cardiovascular surgery has been on life support for nearly 15 years. This specialty’s claimed collapse has generally been attributed to recent advantages in percutaneous procedures and devices that give the oppor- nity to non-surgeon doctors to accomplish the surgeon’s work. The reality is different. Data suggest that cardiac surgery continues to survive and has not suffered the precipitous decline that was predicted. From the economical standpoint, CABG is much more of a mature market and the size of the opportunity remains impressive and relatively stable, with around 1,500,000 procedures performed annually worldwide, at a total cost approaching 2. 5 billion US$.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode Item holds
E books E books PK Kelkar Library, IIT Kanpur
Available EBK3768
Total holds: 0

Historical overview of vascular anastomoses -- The physiology of blood flow and artery wall -- Mathematic modelling of vascular anastomoses -- Determinants of anastomosis long term patency -- Key issues in sutureless vascular anastomoses -- Coronary surgery: devices for proximal anastomosis -- Coronary surgery: devices for distal anastomoses -- Sutureless anastomotic devices for vascular surgery -- Human body and metal alloys: the never ending fight -- Criteria for vascular anastomosis devices assessment.

When doctors first look at sutureless anastomosis devices created by new technologies, the most frequent comment is how amazingly easy it is to create a vascular anastomosis and, as a direct consequence, they believe anybody could play the role of the cardiovascular surgeon. Pessimistic c- diovascular surgeons, on their side, think that creating a machine capable of perfectly reproducing their core activity, which consists in making an- tomosis, will kill their profession. Actually, no medical specialty’s demise has been more often predicted and, at the same time, more greatly ex- gerated than that of cardiovascular surgery. According to its detractors, - ginning in the late 1980s with the angioplasty boom, continuing in the mid-1990s with the introduction of bare metal stents, and then more - cently with the introduction of drug-eluting stents, cardiovascular surgery has been on life support for nearly 15 years. This specialty’s claimed collapse has generally been attributed to recent advantages in percutaneous procedures and devices that give the oppor- nity to non-surgeon doctors to accomplish the surgeon’s work. The reality is different. Data suggest that cardiac surgery continues to survive and has not suffered the precipitous decline that was predicted. From the economical standpoint, CABG is much more of a mature market and the size of the opportunity remains impressive and relatively stable, with around 1,500,000 procedures performed annually worldwide, at a total cost approaching 2. 5 billion US$.

There are no comments for this item.

Log in to your account to post a comment.

Powered by Koha